Pure Global
NCT06394557

Evaluation of In-office Bleaching-induced Sensitivity With 2 or 7 Days Interval Between Sessions

Universidade Federal Fluminense·ClinicalTrials.gov·procedureRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Tooth Sensitivity
Drug/Device/Intervention
In-office Dental Bleaching Conventional
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Universidade Federal Fluminense
Location
Nova Friburgo, Brazil
Timeline & enrollment
Phase
N/A
Start date
Aug 14, 2023
End date
Jul 01, 2024
Enrollment
47 participants
Primary outcome

Tooth sensitivity,Tooth sensitivity,Tooth sensitivity

Summary

Clinical randomized single-blind trial, used to measure the level of tooth sensitivity (TS)
 after in-office dental bleaching sessions, on volunteers using a modified visual analog scale
 (VAS). We selected for this study, 47 patients with color 2M2 or darker (Using 0M1 - 5M3 Vita
 bleaching shade guide). We performed two bleaching sessions with an acidic 35% hydrogen
 peroxide gel with either a 1-week or 2-day interval. We recorded the TS up to 48 h with a VAS
 scale and the color at baseline and 30 days after bleaching with a value-oriented shade guide
 and a spectrophotometer. The risk and intensity of TS and the color change were compared
 between the two groups.

ICD-10 classifications
Anomalies of tooth positionTeething syndromeDisturbances in tooth eruptionDisturbances in tooth formationOther disorders of tooth development
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06394557
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06394557 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidade Federal Fluminense and is currently Recruitment Completed. The study focuses on Tooth Sensitivity. Target enrollment is 47 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.